207 related articles for article (PubMed ID: 11154173)
1. Appraisal of transarterial immunoembolization for hepatocellular carcinoma: a clinicopathologic study.
Yoshida T; Sakon M; Umeshita K; Kanai T; Miyamoto A; Takeda T; Gotoh M; Nakamura H; Wakasa K; Monden M
J Clin Gastroenterol; 2001 Jan; 32(1):59-65. PubMed ID: 11154173
[TBL] [Abstract][Full Text] [Related]
2. New development of transarterial immunoembolization (TIE) for therapy of hepatocellular carcinoma with intrahepatic metastases.
Kanai T; Monden M; Sakon M; Gotoh M; Umeshita K; Hasuike Y; Nakano H; Monden T; Murakami T; Nakamura H
Cancer Chemother Pharmacol; 1994; 33 Suppl():S48-54. PubMed ID: 8137485
[TBL] [Abstract][Full Text] [Related]
3. [Transarterial immuno-embolization therapy in patients with hepatocellular carcinoma].
Eguchi H; Takeda T; Sakon M; Umeshita K; Ohzato H; Dono K; Gotoh M; Monden T; Monden M
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1665-7. PubMed ID: 9382502
[TBL] [Abstract][Full Text] [Related]
4. Role of intratumoral infiltrating macrophages after transarterial immunoembolization for hepatocellular carcinoma.
Kenjo A; Sato T; Marubashi S; Saito T; Tsuchiya T; Kimura T; Sato N; Takahashi A; Ohira H; Gotoh M
J Hepatobiliary Pancreat Sci; 2016 May; 23(5):298-304. PubMed ID: 26946336
[TBL] [Abstract][Full Text] [Related]
5. [Immunological and histological analyses of transarterial immuno-embolization therapy (TIE) in operable patients with hepatocellular carcinoma].
Yoshida T; Kanai T; Monden M; Kita Y; Sakon M; Gotoh M; Umeshita K; Hanike Y; Monden T; Nakamura H
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2111-4. PubMed ID: 7944415
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic value of hepatectomy and transcatheter arterial embolization (TAE) for hepatocellular carcinoma].
Takeda S; Tashiro H; Koho H; Abe Y; Nagafuchi Y; Okamoto K; Ohsato K
Nihon Geka Gakkai Zasshi; 1992 Sep; 93(9):1100-3. PubMed ID: 1335114
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases.
Higuchi T; Kikuchi M; Okazaki M
Cancer; 1994 May; 73(9):2259-67. PubMed ID: 7513245
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma with adjacent organ extension: the enhancement of preoperative transcatheter arterial embolization and the results of surgical resection.
Wu CC; Ho WL; Liu TJ
Surg Today; 1994; 24(10):882-8. PubMed ID: 7894185
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of transarterial immuno-embolization therapy (TIE) in operable patients with hepatocellular carcinoma].
Miyamoto A; Kanai T; Monden M; Sakon M; Gotoh M; Umeshita K; Hasuike Y; Nakano H; Takiguchi S; Yokoyama S
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1465-8. PubMed ID: 8396897
[TBL] [Abstract][Full Text] [Related]
10. [Hepatectomy after transcatheter arterial embolization (TAE) for hepatocellular carcinomas].
Hiroshashi K; Sakai K; Kinoshita H; Igawa S; Matsuoka S; Nagata E; Kubo S
Nihon Geka Gakkai Zasshi; 1985 May; 86(5):555-65. PubMed ID: 2991731
[TBL] [Abstract][Full Text] [Related]
11. [The efficacy of transarterial immuno-embolization therapy in patients with hepatocellular carcinoma].
Shimizu J; Kanai T; Monden M; Sakon M; Gotoh M; Umeshita K; Tarui T; Monden T; Mori T; Tomoda K
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1437-40. PubMed ID: 1326909
[TBL] [Abstract][Full Text] [Related]
12. Sequential transarterial chemoembolization and portal vein embolization before resection is a valid oncological strategy for unilobar hepatocellular carcinoma regardless of the tumor burden.
Ronot M; Cauchy F; Gregoli B; Breguet R; Allaham W; Paradis V; Soubrane O; Vilgrain V
HPB (Oxford); 2016 Aug; 18(8):684-90. PubMed ID: 27485063
[TBL] [Abstract][Full Text] [Related]
13. [The efficacy of transarterial immuno-embolization therapy in patients with unresectable hepatocellular carcinoma].
Kishi K; Kanai T; Sakon M; Fujiwara Y; Takeda Y; Higaki N; Yamada T; Taniguchi K; Hasuike Y; Gotoh M
Gan To Kagaku Ryoho; 1995 Sep; 22(11):1590-3. PubMed ID: 7574767
[TBL] [Abstract][Full Text] [Related]
14. Resection of hepatocellular carcinoma after transcatheter arterial embolization. Reevaluation of the advantages and disadvantages of preoperative embolization.
Hwang TL; Chen MF; Lee TY; Chen TJ; Lin DY; Liaw YF
Arch Surg; 1987 Jul; 122(7):756-9. PubMed ID: 3036038
[TBL] [Abstract][Full Text] [Related]
15. [The assessment of preoperative transcatheter arterial embolization (TAE) for hepatocellular carcinoma (HCC)--the comparison between "whole-liver" TAE and "lobar or segmental" TAE].
Masutani S; Sasaki Y; Imaoka S; Ohashi I; Ishikawa O; Furukawa H; Fukuda I; Kabuto T; Fujita M; Koyama H
Nihon Shokakibyo Gakkai Zasshi; 1991 Nov; 88(11):2757-62. PubMed ID: 1662730
[TBL] [Abstract][Full Text] [Related]
16. Hepatectomy with chemoembolization for treatment of hepatocellular carcinoma.
Ochiai T; Sonoyama T; Hironaka T; Yamagishi H
Hepatogastroenterology; 2003; 50(51):750-5. PubMed ID: 12828078
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic results of resection, transcatheter arterial embolization and percutaneous transhepatic ethanol injection in 3225 patients with hepatocellular carcinoma: a retrospective multicenter study.
Ryu M; Shimamura Y; Kinoshita T; Konishi M; Kawano N; Iwasaki M; Furuse J; Yoshino M; Moriyama N; Sugita M
Jpn J Clin Oncol; 1997 Aug; 27(4):251-7. PubMed ID: 9379514
[TBL] [Abstract][Full Text] [Related]
18. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.
Su TS; Lu HZ; Cheng T; Zhou Y; Huang Y; Gao YC; Tang MY; Jiang HY; Lian ZP; Hou EC; Liang P
BMC Cancer; 2016 Nov; 16(1):834. PubMed ID: 27809890
[TBL] [Abstract][Full Text] [Related]
19. [The effects of preoperative transcatheter arterial chemoembolization (TAE) for the recurrence of hepatocellular carcinoma (HCC) from the viewpoint of consecutive tumor necrosis effect].
Nakanishi K; Une Y; Haneda T; Okubo H; Tomioka N; Shimamura T; Matsushita M; Sato N; Nakajima Y; Uchino J
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1412-4. PubMed ID: 8854766
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of preoperative lobar or segmental ablation via transarterial administration of ethiodol and ethanol mixture for treatment of hepatocellular carcinoma: clinical study.
Cheng Y; Kan Z; Chen C; Huang T; Chen T; Yang B; Ko S; Lee T
World J Surg; 2000 Jul; 24(7):844-50; discussion 850. PubMed ID: 10833253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
